Post: A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies’ access efforts are

AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) — The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue of how some of the largest pharmaceutical companies are reaching patients worldwide, especially in low- and middle-income countries (LMICs).

Ahead of the 2024 Access to Medicine Index, the Foundation examined the patient reach commitments and measurement approaches of the 20 companies that will be ranked in the upcoming Index in November. The analysis identified 42 unique approaches to measuring patient reach, each with varying degrees of comprehensiveness. Companies like AstraZeneca, Novartis, and Roche are leading the way with more nuanced approaches that go beyond simply tracking sales, enhancing the accuracy of their patient reach calculations. The report also emphasises that while many companies have set ambitious goals for reaching more patients in LMICs, these commitments could benefit from further refinement in order to drive real change.

What does the report find?

Encouragingly, 19 of the 20 companies assessed have reported using approaches to track the patients they reach with their essential medicines in LMICs, with the exception of AbbVie. However, these approaches vary widely.

Notably, many pharmaceutical companies set ambitious goals and make public commitments to expand their global patient reach, particularly in LMICs. A few of these commitments, including those set by Bayer, GSK and Johnson & Johnson, are clear, measurable and ambitious, with targets aligned with high global disease burdens.

However, findings also reveal significant potential for companies to refine their commitments and better their efforts to reach those in need. For example, the major insulin manufacturers—Eli Lilly, Novo Nordisk, and Sanofi—control over 90% of the market share and have pledged to expand access to their products in LMICs. Yet, their commitments collectively address only 1% of the diabetes prevalence within the 113 LMICs in the scope of the Index, which currently stands at over 350 million cases out of the global 525 million cases, according to Global Burden of Disease data from 2021.

“We have seen that the pharmaceutical industry is making ambitious commitments to reach more patients worldwide. However, this report reveals that there is still much work to be done in achieving meaningful impact and calls for urgent steps to ensure lifesaving products reach every patient, everywhere.”

– Jayasree K. Iyer, CEO, Access to Medicine Foundation.

Next steps

To address chronic health inequity, the pharma industry and its partners must embed patient reach at the core of their business and partnerships. Using the key findings and recommendations identified in the Foundation’s report, companies can strengthen and expand their current approaches, as well as collaborate and learn from one another.

Contact: Divya Verma, Head of Communication

[email protected] / +31 (0) 20 215 3535

GlobeNewswire Distribution ID 1000990240

BII Unveils $6.7 Billion Equity Strategy for Africa in Nairobi

Nairobi:British International Investment (BII), the UK development finance institution, has announced a significant new strategy in Nairobi, focusing on investing $6.7 billion in equity across Africa from 2026 to 2031. This initiative aims to attract …

COP31 Scheduled for November 2026 in Antalya, Türkiye

Antalya:The 31st Conference of the Parties to the UN Framework Convention on Climate Change is set to take place from 9 to 20 November 2026 in Antalya, Türkiye. This global gathering aims to address the accelerating climate crisis as nations work towa…

First Simandou Mining Summit Draws Over 1,000 Delegates to Conakry

Conakry:Guinea is hosting the inaugural Simandou Mining Summit in Conakry from November 11 to 14. The event, themed “The Mining Industry A Catalyst for Economic Sovereignty,” is organized by the Simandou Strategic Committee in collaboration with the M…

Biovéa Biomass Power Plant Inaugurated in Ayébo, Ivory Coast

Ayébo:The 46 MW Biovéa Énergie biomass power plant was inaugurated in Ayébo, located in the Aboisso sub-prefecture of the Sud-Comoé region. The inauguration ceremony, held on November 5, was attended by the Minister of Mines, Petroleum and Energy, Mam…

Ethiopia’s GDP Reaches $210.7 Billion Following Rebasing

Addis Ababa:Ethiopia’s Finance Minister, Fitsum Assefa, has announced the results of the GDP rebasing with the Ethiopian fiscal year 2017 (2024/25) as the new base year. The announcement was made in Addis Ababa on November 4.

According to Africa New…